Haptens useful in evaluating inhibition of PNN elastase by N-sub

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Albumin

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 71, 436543, 530367, 530386, 530405, 530807, 549469, 564 56, C07K 308, C07C27504, C07D30779, G01N 3368

Patent

active

052761398

ABSTRACT:
N-substituted azetidinones are a class of inhibitors of human leukocytes elastase which are known to be useful in the treatment of a wide variety of antiinflammatory and antidegenerative diseases. In inhibiting elastase, the therapeutic agents are shown to form a characteristic stable complex with the enzyme. In the radioimmune assay disclosed herein, the inhibitor-enzyme complex is advantageously hydrolyzed and specific product(s) of the hydrolysis are measured. The assays are useful in a clinical setting, for determining appropriate dosage and assessing the effectiveness of treatment.

REFERENCES:
patent: 4680391 (1987-07-01), Firestone et al.
Chemical Abstracts 75:35,848 (1971); 77: 135,029 (1972); 78:110,819 (1971); 115:126,395 (1991).
Chem Abstracts, vol. 78, No. 17, Apr. 30, 1973.
Chem Abstracts, vol. 115, No. 13, Sep. 30, 1991.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Haptens useful in evaluating inhibition of PNN elastase by N-sub does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Haptens useful in evaluating inhibition of PNN elastase by N-sub, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Haptens useful in evaluating inhibition of PNN elastase by N-sub will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-308320

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.